Page last updated: 2024-12-10

l-ccg iii

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5310957
CHEMBL ID285369
SCHEMBL ID22640266
MeSH IDM0439236

Synonyms (20)

Synonym
l-ccg-iii
NCGC00024540-02
CHEMBL285369 ,
2-(amino-carboxy-methyl)-cyclopropanecarboxylic acid (d-cga-d)
(1r,2s)-2-((s)-amino-carboxy-methyl)-cyclopropanecarboxylic acid
bdbm50004899
AKOS006272532
(2s,3s,4r)-ccg
(2s,1's,2'r)-2-(carboxycyclopropyl)glycine
l-ccg-lll
SR-01000597641-1
sr-01000597641
HY-100838
(2s,3s,4r)-2-(carboxycyclopropyl)glycine
(1r,2s)-2-((s)-amino(carboxy)methyl)cyclopropanecarboxylic acid
SCHEMBL22640266
cis-|a-(carboxycyclopropyl)glycine
CS-0020491
(1r,2s)-2-((s)-amino(carboxy)methyl)cyclopropanecarboxylicacid
PD071279
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Excitatory amino acid transporter 2Homo sapiens (human)IC50 (µMol)4.00000.95504.465411.0000AID517105
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (24)

Processvia Protein(s)Taxonomy
glutathione biosynthetic processExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic ion transportExcitatory amino acid transporter 2Homo sapiens (human)
neurotransmitter transportExcitatory amino acid transporter 2Homo sapiens (human)
chemical synaptic transmissionExcitatory amino acid transporter 2Homo sapiens (human)
visual behaviorExcitatory amino acid transporter 2Homo sapiens (human)
response to xenobiotic stimulusExcitatory amino acid transporter 2Homo sapiens (human)
response to woundingExcitatory amino acid transporter 2Homo sapiens (human)
L-glutamate transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
telencephalon developmentExcitatory amino acid transporter 2Homo sapiens (human)
adult behaviorExcitatory amino acid transporter 2Homo sapiens (human)
multicellular organism growthExcitatory amino acid transporter 2Homo sapiens (human)
response to amino acidExcitatory amino acid transporter 2Homo sapiens (human)
positive regulation of glucose importExcitatory amino acid transporter 2Homo sapiens (human)
protein homotrimerizationExcitatory amino acid transporter 2Homo sapiens (human)
transepithelial transportExcitatory amino acid transporter 2Homo sapiens (human)
L-aspartate transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
D-aspartate import across plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
cellular response to cocaineExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic anion transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
L-glutamate import across plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
neurotransmitter reuptakeExcitatory amino acid transporter 2Homo sapiens (human)
L-aspartate import across plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
transport across blood-brain barrierExcitatory amino acid transporter 2Homo sapiens (human)
cysteine transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
L-glutamate transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
high-affinity L-glutamate transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
protein bindingExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic anion transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
glutamate:sodium symporter activityExcitatory amino acid transporter 2Homo sapiens (human)
cysteine transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
metal ion bindingExcitatory amino acid transporter 2Homo sapiens (human)
neutral L-amino acid transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
presynaptic membraneExcitatory amino acid transporter 2Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
cell surfaceExcitatory amino acid transporter 2Homo sapiens (human)
membraneExcitatory amino acid transporter 2Homo sapiens (human)
axolemmaExcitatory amino acid transporter 2Homo sapiens (human)
vesicleExcitatory amino acid transporter 2Homo sapiens (human)
cell bodyExcitatory amino acid transporter 2Homo sapiens (human)
neuron projection terminusExcitatory amino acid transporter 2Homo sapiens (human)
membrane raftExcitatory amino acid transporter 2Homo sapiens (human)
astrocyte projectionExcitatory amino acid transporter 2Homo sapiens (human)
glutamatergic synapseExcitatory amino acid transporter 2Homo sapiens (human)
membrane protein complexExcitatory amino acid transporter 2Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID26365pKa value by 1H NMR titration experiments; pK11996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors.
AID517105Inhibition of human GLT1 expressed in Xenopus laevis Oocytes assessed as reduction of [3H]-glutamate uptake after 10 mins by scintillation counting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Identification of selective norbornane-type aspartate analogue inhibitors of the glutamate transporter 1 (GLT-1) from the chemical universe generated database (GDB).
AID26367pKa value by 1H NMR titration experiments; pK31996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors.
AID144456Displacement of [3H]CPP from N-methyl-D-aspartate glutamate receptor in rat brain membrane1992Journal of medicinal chemistry, Apr-17, Volume: 35, Issue:8
Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists.
AID26366pKa value by 1H NMR titration experiments; pK21996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.94 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]